Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin-Hesperidin vs Loratadine for G-CSF Induced Bone Pain
NCT07300735Recruiting
- Sponsor
- Alexandria University
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of micronized purified flavonoid fraction and loratadine in bone pain (4 arms), sponsored by Alexandria University. Primary endpoints: Bone Pain Severity assessed by Brief Pain Inventory at 5 days, Bone Pain Interference assessed by Brief Pain Inventory at 5 days and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
micronized purified flavonoid fractionloratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT07300735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300735.